Literature DB >> 1338309

Synthesis and antitumour activities of quinolone antineoplastic agents.

D T Chu1, R Hallas, J J Clement, J Alder, E McDonald, J J Plattner.   

Abstract

DNA topoisomerases, found in all prokaryotic and eukaryotic cells, play a key role in controlling the topological state of DNA. Quinolone antibacterial agents have been shown to be inhibitors of DNA gyrase, a bacterial topoisomerase II enzyme. The eukaryotic topoisomerase II is the target of various cytotoxic agents such as adriamycin and etoposide. Recently, several quinolones having C-8 fluoro and C-8 chloro substituents have been found to have cytotoxic activities and to interact with mammalian topoisomerase II. In searching for an antitumour agent of the quinolone class, we identified several quinolones having excellent in vitro cytotoxic activity. A-74932 also possesses good activity in vivo against both systemic tumour and subcutaneously implanted murine solid tumours as well as human tumour xenografts. The chemical synthesis as well as biological properties of A-74932 are described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338309

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  5 in total

1.  Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.

Authors:  Gunther Kern; Tiffany Palmer; David E Ehmann; Adam B Shapiro; Beth Andrews; Gregory S Basarab; Peter Doig; Jun Fan; Ning Gao; Scott D Mills; John Mueller; Shubha Sriram; Jason Thresher; Grant K Walkup
Journal:  J Biol Chem       Date:  2015-07-06       Impact factor: 5.157

Review 2.  A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.

Authors:  Gregory S Bisacchi; Michael R Hale
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 3.  A review on the synthesis of heteroannulated quinolones and their biological activities.

Authors:  Yaseen A M M Elshaier; Ashraf A Aly; Mohamed Abd El-Aziz; Hazem M Fathy; Alan B Brown; Mohamed Ramadan
Journal:  Mol Divers       Date:  2021-10-26       Impact factor: 3.364

4.  (E)-1-Ethyl-4-oxo-N'-(4-pyridylmethyl-ene)-1,4-dihydroquinoline-3-carbo-hydrazide.

Authors:  Fernanda da C Santos; Pedro Netto Batalha; Anna Claudia Cunha; Rafael A Alão; Vitor Francisco Ferreira; Maria Cecilia B V de Souza; Sauli Santos
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-16

5.  Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours.

Authors:  J D Alder; K P Jarvis; K C Marsh; L L Klein; J J Clement
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.